Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

Increased levels of the inflammatory biomarker high-sensitivity C-reactive protein predict cardiovascular events. Since statins lower levels of high-sensitivity C-reactive protein as well as cholesterol, we hypothesized that people with elevated high-sensitivity C-reactive protein levels but without hyperlipidemia might benefit from statin treatment.We randomly assigned 17,802 apparently healthy men and women with low-density lipoprotein (LDL)...